ScholarIQanswers from OpenAlex & ORCID
Daniel Cattran
ResearcherPublications, citations & collaboration network
Daniel Cattran is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Daniel Cattran have?
ScholarIQindexed works
Daniel Cattran has 154 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Daniel Cattran have?
ScholarIQcitation count
Daniel Cattran has 12,055 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Daniel Cattran?
ScholarIQh-index
Daniel Cattran has an h-index of 53 in OpenAlex.
What is the i10-index of Daniel Cattran?
ScholarIQi10-index
Daniel Cattran has an i10-index of 91 in OpenAlex.
What is the OpenAlex record for Daniel Cattran?
ScholarIQopenalex
The OpenAlex for Daniel Cattran is on the source record.
What are the most-cited papers on Daniel Cattran?
ScholarIQmost cited works
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility
A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Ian S.D. Roberts, H. Terence Cook, Stéphan Troyanov, Charles E. Alpers, Alessandro Amore, Jonathan Barratt, F. Berthoux, Stephen M. Bonsib, Jan A. Bruijn, Daniel Cattran, Rosanna Coppo, Vivette D. D’Agati, Giuseppe D’Amico, Steven N. Emancipator, Francesco Emma, John Feehally, Franco Ferrario, Fernando C. Fervenza, Sandrine Florquin, Agnes B. Fogo, Colin Geddes, Hermann-Josef Groene, Mark Haas, Andrew M. Herzenberg, Prue Hill, Ronald J. Hogg, Stephen I‐Hong Hsu, J. Charles Jennette, Kensuke Joh, Bruce A. Julian, Tetsuya Kawamura, Fernand Mac–Moune Lai, Lei-Shi Li, Philip Kam‐Tao Li, Zhi-Hong Liu, Bruce Mackinnon, Sergio Mezzano, Francesco Paolo Schena, Yasuhiko Tomino, Patrick D. Walker, Haiyan Wang, Jan J. Weening, Nori Yoshikawa, Hong Zhang
Remission of Proteinuria Improves Prognosis in IgA Nephropathy
Heather N. Reich, Ste[Combining Acute Accent]phan Troyanov, James W. Scholey, Daniel Cattran
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Fernando C. Fervenza, Gerald B. Appel, Sean J. Barbour, Brad H. Rovin, Richard Lafayette, Nabeel Aslam, Jonathan Ashley Jefferson, Patrick E. Gipson, Dana V. Rizk, John R. Sedor, James F. Simon, Ellen T. McCarthy, Paul Brenchley, Sanjeev Sethi, Carmen Ávila-Casado, Heather Beanlands, John C. Lieske, David Philibert, Tingting Li, Leslie F. Thomas, Dolly F. Green, Luis A. Juncos, Lada Beara‐Lasić, Samuel S. Blumenthal, Amy N. Sussman, Stephen B. Erickson, Michelle Hladunewich, Pietro A. Canetta, Lee A. Hebert, Nelson Leung, Jay Radhakrishnan, Heather N. Reich, Samir V. Parikh, Debbie S. Gipson, Dominic K. Lee, Bruno R. da Costa, Peter Jüni, Daniel Cattran
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
Sean J. Barbour, Rosanna Coppo, Hong Zhang, Zhi-Hong Liu, Yusuke Suzuki, Keiichi Matsuzaki, Ritsuko Katafuchi, Lee Er, Gabriela Espino-Hernández, S. Joseph Kim, Heather N. Reich, John Feehally, Daniel Cattran, International IgA Nephropathy Network
Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy
Laurence H. Beck, Fernando C. Fervenza, David M. Beck, Ramon Bonegio, Fahim Malik, Stephen B. Erickson, Fernando G. Cosio, Daniel Cattran, David J. Salant